MedPath

Tissue pharmacokinetics of daptomycin measured by in vivo microdialysis in patients with diabetic foot infectio

Conditions
A group of adult male or female patients with documented diabetes and bacterial soft tissue infection of the foot who must be subjected to undergo intravenous antimicrobial therapy with broad-spectrum antibiotics.
Registration Number
EUCTR2007-007640-10-DE
Lead Sponsor
PD Dr. med. K-H. Konz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Written informed consent to participate in the study.
2. Male or female patient of 18 years of age or older.
3. Patient suffers from documented diabetes and soft tissue infection of the lower limb.
4. Requires intravenous broad-spectrum anti-microbial therapy
5. CRP higher than 5 mg/dl at baseline
6. Patient has no relevant renal dysfunction indicated by a creatinine clearance =40 ml/min as determined by the Cockcroft-Gault equation using actual body weight (Appendix 4).
7. Negative urine pregnancy test in females of childbearing potential
8. Patient is willing to participate in the study, follow protocol study treatment regimen, and comply with all planned assessments.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. Treatment with the study drug within the past three weeks prior to study enrolment.
2. Site of infection other than infection of the lower limb
3. History of hypersensitivity to the study drug
4. Patients submitted to the hospital with known pathogens resistant to study drug.
5. Patient with a neutrophils count <1000/m3.
6. Use of any other investigational therapy at the time of enrolment, or within 30 days or 5 half-lives before inclusion into, whichever is longer.
7. Patients unable or unwilling to adhere to the study-designated procedures and restrictions.
8. Unable to understand the nature, purpose and extent of the study
9. Nursing women

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath